Predicting which HIV patients will respond better to future therapeutic vaccine

18 julio 2014

HIV patients with a higher level of a particular biomarker, or a measurable indicator found in the blood, may respond more favorably to an experimental immune activating vaccine, a study suggests. Experts believe the findings might lead to a more customized vaccine for certain patients, which potentially might permit them to come off antiretrovirals, drugs used to treat HIV.